Primary Immune Deficiency Consortium Conference

该补助金用于研究员和教师的旅行和与举办临床免疫学会（CIS）有关的费用。 2006年、2007年和2008年原发性免疫缺陷病联盟会议。第一个NIH支持 2005年5月在波士顿举行了原发性免疫缺陷联合会会议， 成功目前的赠款申请将提供资金，以支持与会者的差旅费，并协助 项目开发时间为3年。将从制药公司和 生物技术公司。独联体原发性免疫缺陷联合会会议的使命是 利用已经实施的指导计划，培训年轻的调查人员进行诊断， 在密集的会议中治疗原发性免疫缺陷疾病， 互动参与。独联体与由国家开发计划署资助的USIDNet联合会合作， 卫生研究所将于2006年6月在旧金山弗朗西斯科举办另一个为期一天的强化课程， 加州。随后的两次会议将在美国大陆的其他两个主要城市举行，以配合 这是非常成功的FOCIS会议的第一天，扩大了广大受众的参与。的话题 这些会议将是原发性免疫缺陷，并将包括面向更多的高级研究员， 培训，初级教师，以及在该领域的著名专家。首要目标是继续推进 教育的诊断，分子缺陷，并发症，和治疗这些复杂的免疫 缺乏性疾病第二个目标是发展这一领域的新科学家的职业生涯， 学术医学;并提高临床免疫学及其在科学中的重要性的认识 发现和临床应用。第三组目标是促进未来的合作， 不同医学中心和国家的年轻研究者，以及新研究者和 该领域经验丰富的医生/科学家。这些会议将包括正式介绍，案例和 与新的研究人员和经验丰富的教师进行小组讨论。每次会议的与会者将 包括二十（20）名教员和六十（60）名年轻研究员。主要主题将集中在：诊断 免疫缺陷;遗传学，免疫重建，以及标准和新疗法的使用。

This grant is for fellows' and faculty travel and expenses related to holding Clinical Immunology Society (CIS) Primary Immune Deficiency Consortium Conferences, 2006, 2007, and 2008. The first NIH supported Primary Immune Deficiency Consortium Conference was held May 2005 in Boston, and was highly successful. This current grant request will provide the funding to support travel for the participants and assist with program development for a further 3 years. Additional funding will be solicited from pharmaceutical and biotechnology companies. The mission of the CIS Primary Immune Deficiency Consortium Conferences are to capitalize upon a mentoring program already in place to train young investigators in the diagnosis and treatment of primary immunodeficiency diseases in intensive meetings in a setting that encourages interactive participation. The CIS, in collaboration with the USIDNet Consortium funded by the National Institutes of Health, will develop another intensive one day course to be held in June 2006 in San Francisco, California. Two subsequent meetings will be held in 2 other continental US major cities to coincide with the first day of the highly successful FOCIS meetings to amplify participation by a wide audience. The topic of these conferences will be Primary Immunodeficiency, and will include geared towards more senior fellows in training, junior faculty, as well as noted experts in the field. The primary goal is to continue to advance education on the diagnosis, molecular defects, complications, and treatment of these complex immune deficiency diseases. The secondary goals are to develop the careers of new scientists in this area of academic medicine; and to enhance awareness of Clinical Immunology and its importance in scientific discoveries and clinical applications. The third set of goals is to stimulate future collaborations between young investigators in different medical centers and countries, and between new investigators and experienced physician/scientists in the field. These conferences will include formal presentations, case and panel discussions with new investigators and experienced faculty. Participants at each conference will include twenty (20) faculty and sixty (60) young investigators. Principle topics will focus on: Diagnosis of Immunodeficiency; Genetics, Immune Reconstruction, and the Use of Standard and Novel Therapies.